Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Observational Study of Bevacizumab Plus 5-FU Based Chemotherapy as First Line and Second Line Treatment for Chinese Patients With Metastatic Colorectal Cancer (ML25391)

NCT01319877 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01319877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01319877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Observational Study of Bevacizumab Plus 5-FU Based Chemotherapy as First Line and Second Line Treatment for Chinese Patients With Metastatic Colorectal Cancer (ML25391)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
March 31, 2015
Enrollment
609 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer